Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The American Journal of Managed Care
|
September 13, 2018
The evolution of biomarkers to guide the treatment of metastatic colorectal cancer
Lisa E Davis
Clinical Therapeutics
|
December 25, 2003
Zoledronic acid: a new parenteral bisphosphonate
Edward C Li, Lisa E Davis
The Annals of Pharmacotherapy
|
May 2, 2023
Fixed Versus Body-Sized-Based Dosing of Monoclonal Antibodies
Brian L Erstad, Lisa E Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 1, 2021
The relationship of vancomycin 24-hour AUC and trough concentration
David E Nix, Lisa E Davis, Kathryn R Matthias
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 5, 2022
Response to Rybak et al
David E Nix, Lisa E Davis, Kathryn R Matthias
American Journal of Pharmaceutical Education
|
February 12, 2025
Fixed, Systematically Formed versus Continuously Changing Random Team Assignments and Outcomes in a Therapeutics Course
Ashley M Campbell, Prince Bosiako Antwi, Lisa E Davis, et al.
Cancer Immunology Research
|
August 7, 2019
PD-1 Inhibition Achieves a Complete Metabolic Response in a Patient with Malignant Peripheral Nerve Sheath Tumor
Lisa E Davis, Lauren A Nicholls, Hani M Babiker, et al.
Clinical Breast Cancer
|
April 3, 2020
A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer
Lea E Mollon, Elizabeth J Anderson, Joni L Dean, et al.
International Journal of Breast Cancer
|
July 9, 2020
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
Elizabeth J Anderson, Lea E Mollon, Joni L Dean, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 9, 2012
Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency
Quentin McAfee, Zhihui Zhang, Arabinda Samanta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The American Journal of Managed Care
|
September 13, 2018
The evolution of biomarkers to guide the treatment of metastatic colorectal cancer
Lisa E Davis
Clinical Therapeutics
|
December 25, 2003
Zoledronic acid: a new parenteral bisphosphonate
Edward C Li, Lisa E Davis
The Annals of Pharmacotherapy
|
May 2, 2023
Fixed Versus Body-Sized-Based Dosing of Monoclonal Antibodies
Brian L Erstad, Lisa E Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 1, 2021
The relationship of vancomycin 24-hour AUC and trough concentration
David E Nix, Lisa E Davis, Kathryn R Matthias
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 5, 2022
Response to Rybak et al
David E Nix, Lisa E Davis, Kathryn R Matthias
American Journal of Pharmaceutical Education
|
February 12, 2025
Fixed, Systematically Formed versus Continuously Changing Random Team Assignments and Outcomes in a Therapeutics Course
Ashley M Campbell, Prince Bosiako Antwi, Lisa E Davis, et al.
Cancer Immunology Research
|
August 7, 2019
PD-1 Inhibition Achieves a Complete Metabolic Response in a Patient with Malignant Peripheral Nerve Sheath Tumor
Lisa E Davis, Lauren A Nicholls, Hani M Babiker, et al.
Clinical Breast Cancer
|
April 3, 2020
A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer
Lea E Mollon, Elizabeth J Anderson, Joni L Dean, et al.
International Journal of Breast Cancer
|
July 9, 2020
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
Elizabeth J Anderson, Lea E Mollon, Joni L Dean, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 9, 2012
Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency
Quentin McAfee, Zhihui Zhang, Arabinda Samanta, et al.
Page
of 2